Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present AVEO Pharmaceuticals, Inc. (OTC: AVEO).

Full DD Report for AVEO

Recent News from (OTC: AVEO)

Daily Insider Ratings Round Up 4/10/18: AVEO, IFF, OPK, ICTSF, DXLG, NEWM, HCAP, CONN
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signif...
Source: SeekingAlpha
Date: April, 12 2018 09:42
AVEO Pharmaceuticals (AVEO) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow
The following slide deck was published by AVEO Pharmaceuticals, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 11 2018 12:59
Premarket Gainers as of 9:05 am (04/11/2018)
VHC +23%  on Apple (NASDAQ: AAPL ) patent victory . More news on: VirnetX Holding Corporation, Apple Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 11 2018 09:21
Q4 Biotech Catalyst Watchlist: Phase 3 Clinical Trials
By Slingshot Insights intern Samuel Jordan We have a full slate of exciting Phase 3 data releases for Q2 2018. This article will focus on four that we think are going to be major catalysts for the companies involved. The Phase 3 data addressed in this article come from trials for Esperio...
Source: SeekingAlpha
Date: April, 09 2018 15:35
Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals and Neovasc
NEW YORK, NY / ACCESSWIRE / April 6, 2018 / U.S. markets ended higher on Thursday for their third straight daily gain as technology stocks recover from a series of shortcomings. The Dow Jones Industrial Average rose to 24,505.22, an increase of 0.99 percent, while the S&P 500 Index gain...
Source: ACCESSWIRE IA
Date: April, 06 2018 08:20
AVEO Pharmaceuticals (AVEO) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
The following slide deck was published by AVEO Pharmaceuticals, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 29 2018 13:02
AVEO Oncology Announces Publication of Long-term Follow-up Results from TIVO-1 Extension Study (Study 902) in TKI Refractory RCC
Results Published in the European Journal of Cancer AVEO Oncology (NASDAQ: AVEO) today announced the publication of long-term follow-up results from Study 902, where patients were treated with tivozanib (FOTIVDA ® ) as second-line treatment in advanced renal cell carcinoma (a...
Source: Business Wire
Date: March, 21 2018 16:05
AVEO Pharmaceuticals misses by $0.05, misses on revenue
AVEO Pharmaceuticals (NASDAQ: AVEO ): FY EPS of -$0.08 misses by $0.05 . Revenue of $0.08M (-38.5% Y/Y) misses by $1.17M . Press Release More news on: AVEO Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: March, 13 2018 07:02
AVEO Reports Full Year 2017 Financial Results and Provides Business Update
AVEO Oncology (NASDAQ:AVEO) today reported financial results for the full year ended December 31, 2017 and provided a business update. “Last year was one of major progress for AVEO, with highlights including the first commercial launch of tivozanib (FOTIVDA ® ); the completio...
Source: Business Wire
Date: March, 13 2018 07:00
Investor Expectations to Drive Momentum within AVEO Pharmaceuticals, PTC Therapeutics, NGL Energy Partners LP, Bemis, CorMedix, and Patterson Companies - Discovering Underlying Factors of Influence
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), PTC Therapeutics, Inc. (NASDAQ...
Source: GlobeNewswire
Date: March, 07 2018 08:25

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-212.652.592.672.561,319,050
2018-04-202.652.592.672.561,319,050
2018-04-192.762.652.772.591,526,725
2018-04-182.792.762.832.721,482,135
2018-04-172.812.772.822.741,192,005

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

Short Analysis provided by Squeeze Report.


About AVEO Pharmaceuticals, Inc. (OTC: AVEO)

Logo for AVEO Pharmaceuticals, Inc. (OTC: AVEO)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $345,904,341 - 03/20/2018
  • Issue and Outstanding: 118,867,471 - 03/08/2018

 


Recent Filings from (OTC: AVEO)

Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 16 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: February, 16 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 26 2017
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: December, 15 2017

 

 


Daily Technical Chart for (OTC: AVEO)

Daily Technical Chart for (OTC: AVEO)


Stay tuned for daily updates and more on (OTC: AVEO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AVEO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AVEO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AVEO and does not buy, sell, or trade any shares of AVEO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us